Active Alerts & Bulletins
Advisory: Overdose Events Spike During Cheque Week (September, 2025)
Bulletin: Carfentanil Returning in BC (August, 2025) | Carfentanil Info Sheet
Bulletin: Counterfeit Hydromorphone Tablets (April 2024)
Bulletin: Nitazene (August, 2022) | Nitazine Info Sheet
Bulletin: Xylazine (January, 2022) | Xylazine Info Sheet
Bulletin: Levamisole (July, 2021) | Levamisole Info Sheet
Bulletin: Benzodiazepines (March, 2021)
See also Susbstance Information Sheets for a complete list.
Alerts
-
VCH - Drug Alert - Vancouver January 09, 2026 • Posted by Vancouver Coastal Health
***Drug Alert - Vancouver - January 9, 2026***
VCH has issued a drug alert.
Blue round counterfeit Oxycodone tablet with imprint 30 M seized in Vancouver tested positive for N-Propionitrile Chlorphine, a novel opioid sometimes referred to as Chlorphine. Chlorphine is not detected by fentanyl test strips. Toxicity due do this opioid can be reversed with naloxone.
Check your drugs: https://www.vch.ca/en/service/drug-checking
-
Fraser Health Region - Toxic Drug Advisory - Regional January 08, 2026 • Posted by Fraser Health
***Toxic Drug Advisory - Fraser Health Region - January 8, 2026***
Medetomidine continues to be detected in the unregulated opioid supply throughout Fraser Health communities.
Medetomidine is a potent non-opioid sedative used in veterinary medicine. It is similar to xylazine ("tranq") but approximately 200 times more potent. Naloxone does not reverse the effects of medetomidine. It should still always be administered in suspected opioid poisonings. Be prepared for prolonged sedation and the need for continuous airway support and monitoring. Medetomidine withdrawal can lead to severe symptoms, most notably a rapid heart rate and dangerously high blood pressure.
Friends, family, and community members using unregulated substances may face increased harms of unknowingly taking different substances than intended.
